Open original FDA record ↗Recall record
- FDA identifier
- Z-2616-2024
- Company in FDA record
- Biointellisense Inc.
- FDA classification date
- Aug 14, 2024
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Software anomaly causing the skin temperature measurement accuracy to be slightly out of specification.
Source facts
- Action
- On 07/19/2024, the firm sent an "URGENT: MEDICAL DEVICE CORRECTION" Letter to customers informing them of a software anomaly that may cause the skin temperature accuracy to be slightly out of specification. Customers are instructed to: - (For customers who wish to receive remote firmware update/fix) Notify clinical staff of the issue as well as the updated skin temperature accuracy for the Affected Product - (For customers who do not wish to receive remote firmware update/fix) Please stop use of the Affected Devices and return them to BioIntelliSense, where possible. Notify or make aware all clinical staff of the recall issues and notify any additional facilities where the Affected Devices may have been further transferred. For questions or assistance - contact BioIntelliSense Customer Support at 888.908.8804 or email address - support@biointellisense.com
- Initiated
- 2024-07-19
- Root cause
- Device Design
- Distribution
- U.S.: CA, CO, MA, TN, and TX O.U.S.: not provided
- Recall number
- Z-2616-2024
- Recall status
- Open, Classified
- CDRH record ID
- 208859
- FDA classified
- 2024-08-14
- Recall event number
- 94943